Ten to 25% of people with late-onset Alzheimer's disease (AD) present with prominent executive deficits. Names such as frontal variant AD, executive prominent AD, and dysexecutive AD have been applied to this phenomenon. Little is known about traditional or genetic risk factors for dysexecutive AD. The overarching goal of this project is to further our understanding of the genetic architecture and clinical epidemiology of dysexecutive AD in the hopes of ultimately developing disease- modifying treatments. This project will leverage large-scale genome-wide genotype and sequence data and cognitive data collected on >17,000 participants across 19 collaborating studies. The investigators will use modern psychometric methods to co-calibrate cognitive data to develop scores on the same metric for memory and executive functioning. The investigators will use these scores to determine a continuous dysexecutive spectrum phenotype they have found to be highly heritable, with a pattern of heritability entirely distinct from that of AD. The investigators will leverage genome-wide genotype data for Aim 1. Five of the collaborating studies are prospective cohort studies with extensive cognitive and clinical data from >10,000 participants. The investigators will leverage these data for Aim 2. Several funding mechanisms are producing whole genome and whole exome sequencing data for people with AD. The investigators will leverage these data for Aim 3. Taken together, these investigations promise to improve what is known about dysexecutive AD, a highly heritable and devastating AD subtype. This work may identify genetic loci associated with risk for dysexecutive AD, which in turn may lead to development of drugs that could dramatically improve the lives of people with this condition.

Public Health Relevance

The investigators propose to leverage extensive genetic, clinical, and cognitive data from 19 collaborating studies with >17,000 participants with Alzheimer's disease (AD) to further the understanding of dysexecutive AD, a devastating AD subtype. A series of genetic and epidemiological investigations are proposed. These investigations would dramatically increase the state of knowledge of this AD subtype, and may hasten the development of disease-modifying drugs.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG042437-02
Application #
8919195
Study Section
Neurological, Aging and Musculoskeletal Epidemiology (NAME)
Program Officer
Miller, Marilyn
Project Start
2014-09-01
Project End
2018-05-31
Budget Start
2015-07-01
Budget End
2016-05-31
Support Year
2
Fiscal Year
2015
Total Cost
$631,560
Indirect Cost
$89,424
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Fardo, David W; Gibbons, Laura E; Mukherjee, Shubhabrata et al. (2017) Impact of home visit capacity on genetic association studies of late-onset Alzheimer's disease. Alzheimers Dement 13:933-939
Liu, Kefei; Yao, Xiaohui; Yan, Jingwen et al. (2017) Transcriptome-Guided Imaging Genetic Analysis via a Novel Sparse CCA Algorithm. Graphs Biomed Image Anal Comput Anat Imaging Genet (2017) 10551:220-229
Hao, Xiaoke; Li, Chanxiu; Yan, Jingwen et al. (2017) Identification of associations between genotypes and longitudinal phenotypes via temporally-constrained group sparse canonical correlation analysis. Bioinformatics 33:i341-i349
Hao, Xiaoke; Li, Chanxiu; Du, Lei et al. (2017) Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer's Disease. Sci Rep 7:44272
Yao, Xiaohui; Yan, Jingwen; Kim, Sungeun et al. (2017) Two-dimensional enrichment analysis for mining high-level imaging genetic associations. Brain Inform 4:27-37
Du, Lei; Zhang, Tuo; Liu, Kefei et al. (2017) Identifying Associations Between Brain Imaging Phenotypes and Genetic Factors via A Novel Structured SCCA Approach. Inf Process Med Imaging 10265:543-555
Deters, Kacie D; Nho, Kwangsik; Risacher, Shannon L et al. (2017) Genome-wide association study of language performance in Alzheimer's disease. Brain Lang 172:22-29
Crane, Paul K; Trittschuh, Emily; Mukherjee, Shubhabrata et al. (2017) Incidence of cognitively defined late-onset Alzheimer's dementia subgroups from a prospective cohort study. Alzheimers Dement 13:1307-1316
Mukherjee, Shubhabrata; Russell, Joshua C; Carr, Daniel T et al. (2017) Systems biology approach to late-onset Alzheimer's disease genome-wide association study identifies novel candidate genes validated using brain expression data and Caenorhabditis elegans experiments. Alzheimers Dement 13:1133-1142
Li, Huang; Fang, Shiaofen; Contreras, Joey A et al. (2017) Brain explorer for connectomic analysis. Brain Inform 4:253-269

Showing the most recent 10 out of 27 publications